Report DMCA Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.